Combining Eloralintide w/ Tirzepatide/Retatrutide - Dosing Timing

Do the recent Eloralintide plus Tirzepatide trial results show whether the two were given on the same day? The combination worked very well, and I doubt the participants split their Tirzepatide. I would rather keep shots to a minimum if possible.

I chose to add Retatrutide rather than raise Tirzepatide further or shorten the interval because the glucagon effect might help restart loss. My goal is probably to end up on just Retatrutide plus Eloralintide, but getting there without setbacks is tricky. I did not respond well to 2.4 mg semaglutide and am now stalled at 15 mg Tirzepatide, so I am looking for the right mix.

What makes you think three at once would be an overload? I do not see the clear reason for that conclusion.

Very little detail came out with the early trial numbers. My guess is they are aiming for a single product, so same-day weekly shots without splitting. I still think separating the drugs makes it easier to tell which one is causing trouble, even if side effects can show up days later.

Tirzepatide seems stronger on hunger even though both act through GLP-1. The extra heart-rate rise from Retatrutide might explain weaker appetite control because it burns a few more calories. If hunger is the main issue, hitting it through a different route like an amylin agonist could help.

A chart comparing receptor activation for semaglutide, tirzepatide, retatrutide, mazdutide, and survodutide matched published sources when checked.

I use 10 mg each of Retatrutide and Tirzepatide weekly mainly for diabetes control. HbA1c fell from 10.5 to 7.5, dawn phenomenon stopped, and BMI dropped from 31-32 to 27. Earlier 5 mg Tirzepatide alone did little. If weight is not moving at 15 mg Tirzepatide with good eating, the medication may simply not be effective for that person, possibly due to receptor mutations.

Is there any standard way to reconstitute Eloralintide?

How do you schedule the Tirzepatide and Retatrutide shots each week?

There is a full thread on reconstitution choices.

This is a long process. You are already at the top Tirzepatide dose and increasing Retatrutide soon. Adding a third agent risks overwhelming receptors. If monthly progress is still happening, consider lowering or dropping one before adding Eloralintide.

I agree with the idea in principle, but I have not seen solid evidence that GLP-1 or amylin receptors get overwhelmed or desensitized from extra exposure. Side effects from stacking seem like the bigger concern.

Weekly dosing is largely about convenience and adherence. Splitting can give steadier levels and fewer side effects. Starting an amylin agonist on the same day as Tirzepatide caused strong fatigue for several evenings; moving it to a different day helped but fatigue was still noticeable.

In this case I would try it and am interested to see the outcome, though most existing data does not involve micro-dosing Tirzepatide.

I split Retatrutide and semaglutide into four roughly even injections. Eloralintide has a much longer half-life, so splitting it may not add much benefit.

What dose of the amylin agonist produced the three-day fatigue? I just added 0.25 mg last week.

Thank you.

I have been dealing with this for decades. Weight-loss curves flatten in trials, so there is a point where progress stalls. Until I get Eloralintide I will keep raising Retatrutide while monitoring side effects. At 15 mg Tirzepatide plus 4 mg Retatrutide I have none so far. Ideally I would like to settle on Retatrutide plus Eloralintide for broader receptor coverage. I lost 60 lb from January through May but have been stalled for two months with another 120 lb still to go.

I tend to follow my first instinct rather than over-plan. Taking both on a weekly basis seems reasonable. I plan to keep them several days apart and start Eloralintide at 0.5-1 mg. Another reason to stay with weekly timing.

My first amylin agonist dose was 1 mg on the same day as 20 mg Tirzepatide. That was not smart, even though the combination product is given together.

Trial participants reached 9 mg Eloralintide with 15 mg Tirzepatide. Change only one variable at a time when testing: keep Tirzepatide steady for the first couple of weeks while adding Eloralintide, then adjust. That approach makes it clearer what is actually helping.